Company Analysis

BioCryst Pharmaceuticals, Inc. (BCRX)

Nasdaq: BCRX · Biological Products, (No Diagnostic Substances) · Durham, NC · filing with the SEC since 1995
Grade6.1
◀ Past 6.3● Present 5.6▶ Future 6.4

Who runs BioCryst Pharmaceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Stonehouse Jon P
Chief Executive Officer. First filing Jan 2007, latest Sep 2, 2026, 8 filings in all.
Officers reporting now
6
of 14 people with a filing in the last fifteen months
Directors reporting now
8
31 people on the record since 2007
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Stonehouse Jon PChief Executive OfficerJan 2007Sep 2, 2026none
Barnes Alane PChief Legal OfficerAug 2013May 15, 20267 · $3.5M
Menon SandeepChief R&D OfficerApr 2026Apr 7, 2026none
Dullinger RonaldChief Commercial OfficerJan 2026Jan 9, 2026none
Gayer Charles KPresident and CCOJan 2020Dec 23, 2025none
Ghias BabarChief Financial OfficerJul 2025Dec 19, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Frank StevendirectorMay 2025Sep 2, 2026none
Mckee Amy EdirectorSep 2021Sep 2, 20261 · $100,000
Milano VincentdirectorJul 2021Sep 2, 2026none
Milne Jill C.directorJan 2026Sep 2, 2026none
Galson Steven KdirectorSep 2021Jun 15, 2026none
Heggie TheresadirectorDec 2018Jun 15, 20261 · $500,000
Levin Alan GdirectorMar 2020Jun 15, 2026none
Sanders MachelledirectorFeb 2022Jun 15, 20261 · $100,000
Earlier names on the record21, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton BCRX · research, not advice